Prestige Consumer Earnings Estimate

Prestige Consumer Earnings per Share Projection vs Actual

About Prestige Consumer Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Prestige Consumer earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Prestige Consumer estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Prestige Consumer fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter healthcare products in North America, Australia, and internationally. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. PRESTIGE CONS operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 520 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Prestige Stock

Prestige Consumer financial ratios help investors to determine whether Prestige Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prestige with respect to the benefits of owning Prestige Consumer security.